Mr. Alles is keynoting the 2018 Washington State Life Science Summit. We were fortunate to have him answer a couple of questions about the Juno Therapeuticsacquisition, the workforce pipeline problem, and the future of cancerresearch.

Life Science Washington is excited to announce Mr. Mark Alles, Chairman & CEO of Celgene as this year’s keynote speaker. Well known to Washington’s life science community, Celgene is a global leader in the discovery, development, and commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. Mr. Alles has led Celgene for the past two years and currently chairs the executive committee. We look forward to learning what the future holds for Celgene in Seattle, subsequent to its acquisition of Juno Therapeutics.